Array Biopharma (ARRY) 09/10/2016 www.arraybiopharma.com Pipeline: Focuses mostly on developing treatments for cancer. They have a very diverse pipeline with many drug candidates. Product Indication Status Binimetinib / MEK162 Cancer Phase 3 Encorafenib / LGX818 Cancer Phase 3 Selumetinib (AstraZeneca) Cancer Phase 3 Danoprevir (Roche) Hepatitis C Phase 3 Filanesib / ARRY-520 Multiple Myeloma Phase 2 ARRY-797 Indication: LMNA-related DCM Phase 2 ARRY-502 Asthma Phase 2
www.arraybiopharma.com Pipeline: Focuses mostly on developing treatments for cancer. They have a very diverse pipeline with many drug candidates. Product Indication Status Binimetinib / MEK162 Cancer Phase 3 Encorafenib / LGX818 Cancer Phase 3 Selumetinib (AstraZeneca) Cancer Phase 3 Danoprevir (Roche) Hepatitis C Phase 3 Filanesib / ARRY-520 Multiple Myeloma Phase 2 ARRY-797 Indication: LMNA-related DCM Phase 2 ARRY-502 Asthma Phase 2
